By 9:30, the Sensex was lower by 18 points at 27,300 mark and the Nifty dipped by 8 points at 8,165 levels.
Meanwhile, foreign portfolio investors (FPIs) bought shares worth a net Rs 1162.98 crore on Monday, as per provisional data from the stock exchanges.
Also Read
The rupee is weaker at 60.44/45 versus its Monday's close of 60.29/30. Dollar trades at 14-month highs against a basket of major currencies early on Tuesday.
The index of the dollar against six majors currently up 0.27%.
GLOBAL MARKETS
The U.S. dollar was holding broad-based gains in Asia on Tuesday in a boon for shares of Japanese exporters but a burden for oil, gold and stocks in the energy majors.
As the dollar finally broke to a six-year peak on the yen and a one-year top on the euro, Brent oil sank to 16-month lows while gold carved out a three-month trough.
A falling yen tends to be viewed as positive for Japanese exporters and corporate profits, and helped lift the Topix 0.2 percent to 1,301. That was within a whisker of this year's peak at 1,308.08 and a break there would put it on ground last trod in July 2008.
Markets elsewhere in the region were steady with MSCI's broadest index of Asia-Pacific shares outside Japan down a slight 0.1%.
Despite market concerns over China's economy, stocks there have been buoyed by talk of more stimulus and reform measures.
SECTORS & STOCKS
BSE Metal index has slipped by almost 0.5% followed by counters like IT, Banks, Capital Goods and Consumer Durables, all dipping between 0.1-0.4%. However, BSE Healthcare, FMCG and Auto indices have gained between 0.1-0.3%.
The main losers on the Sensex are Hindalco, Infosys, ICICI Bank, Tata Motors, Tata Steel, Sesa Sterlite and Bharti Airtel.
Metal stocks are in focus with the apex court scheduled to announce its decision on coal block allocations.
On the gaining side, Cipla, TCS, GAIL, Tata Power and NTPC have gained between 0.6-1.5%.
Drug maker Cipla has gained nearly 1.5% to Rs 572 on the BSE after the company on Monday announced commercial collaboration with UK-based S&D Pharma in the Czech Republic and Slovakia.
The broader markets are outperforming the benchmark indices- BSE Midcap and Smallcap indices have gained between 0.3-0.4%.
The market breadth in BSE remains positive with 1,048 shares advancing and 568 shares declining.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)